Table 1. Patients characteristics.
Baseline characteristic | N | % |
---|---|---|
Age (years) | ||
Median | 62 | |
Range | 45–77 | |
Gender | ||
Female, n (%) | 9 | 13.85 |
Male, n (%) | 56 | 86.15 |
Histology | ||
Adenocarcinoma, n (%) | 32 | 49.23 |
Scc, n (%) | 33 | 50.77 |
cTumour stage | ||
T2, n (%) | 2 | 3.07 |
T3, n (%) | 54 | 83.07 |
T4, n (%) | 9 | 13.84 |
cNodal stage | ||
N0, n (%) | 24 | 36.92 |
N+, n (%) | 41 | 63.08 |
cMetastasis stage | ||
M0, n (%) | 62 | 95.38 |
M+, n (%) | 3 | 4.61 |
cTNM | ||
cT2N0, n (%) | 2 | 3.08 |
cT3N0, n (%) | 19 | 29.23 |
cT3N+, n (%) | 32 | 49.23 |
cT3N+M+, n (%) | 3 | 4.62 |
cT4N0, n (%) | 3 | 4.62 |
cT4N+, n (%) | 6 | 9.23 |
SPR | ||
1, n (%) | 28 | 43.08 |
2, n (%) | 9 | 13.85 |
3, n (%) | 7 | 10.77 |
4, n (%) | 21 | 32.31 |
TRG | ||
1, n (%) | 34 | 52.31 |
2, n (%) | 11 | 16.92 |
3, n (%) | 6 | 9.23 |
4, n (%) | 11 | 16.92 |
5, n (%) | 3 | 4.62 |
Abbreviations: SPR=size-based pathological response; TRG=tumour regression grade.